biblio
, “2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis”, Molecular Diversity, vol. 26, no. 2, pp. 1227-1242, 2021.
, “Design, synthesis, structural characterization by IR, 1H, 13C, 15N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors”, Chemical Biology & Drug Design, vol. 81, no. 6, pp. 715-729, 2013.
, “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
, “Recursive partitioning analysis and anti-tubercular screening of 3-aminopyrazine-2-carbohydrazide derivatives”, Letters in Drug Design & Discovery, vol. 16, no. 11, pp. 1264-1275, 2019.
, “Synthesis, biological valuation, and QSAR studies of novel pyrazole bearing pyridyl oxadiazole analogues as potential antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 712-727, 2016.
, “On the use of electronegativity and electron affinity based pseudo-molecular field descriptors in developing correlations for quantitative structure-activity relationship modeling of drug activities”, Chemical Biology & Drug Design, vol. 98, no. 2, pp. 258-269, 2021.